Condition
Acute Promyelocytic Leukemia With PML-RARA clinical trials and research
As of November 12, 2026, Find a Trial lists 3 Acute Promyelocytic Leukemia With PML-RARA clinical trials that are recruiting, at sites in 5 countries (most in United States (3), France (1), Italy (1)). By phase: Phase 3 (1), Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 5Countries
Newest Acute Promyelocytic Leukemia With PML-RARA clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| QTX-2101 (oral arsenic) plus ATRA for adults with low- or intermediate-risk APL | Phase 3 | Birmingham, Alabama and 35 other locations | Recruiting | Mar 31, 2026 |
| Using advanced imaging to detect extramedullary myeloid leukemia in newly diagnosed acute myeloid leukemia patients | Phase 1 | Houston, Texas | Recruiting | Mar 17, 2015 |
| Combining tretinoin and arsenic trioxide with or without gemtuzumab ozogamicin for treating acute promyelocytic leukemia | Phase 2 | Houston, Texas and 4 other locations | Recruiting | Aug 4, 2011 |
All recruiting trials (3)
-
QTX-2101 (oral arsenic) plus ATRA for adults with low- or intermediate-risk APL
This Phase 3 trial tests whether an oral arsenic capsule (QTX-2101) combined with ATRA works well and is safe for adults aged 18–70 with newly diagnosed low- or intermediate-risk acute promyelocytic leukemia.
-
Using advanced imaging to detect extramedullary myeloid leukemia in newly diagnosed acute myeloid leukemia patients
This study is testing new imaging methods to see if they can help find extramedullary myeloid leukemia in people who have just been diagnosed with acute myeloid leukemia.
-
Combining tretinoin and arsenic trioxide with or without gemtuzumab ozogamicin for treating acute promyelocytic leukemia
This study is testing a new combination of treatments for people with acute promyelocytic leukemia to see if it helps them stay healthy longer and improves their chances of recovery without causing more side effects.
Related topics
Quick answers
How many Acute Promyelocytic Leukemia With PML-RARA clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (3 trials), France (1 trial), Italy (1 trial), Romania (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.